Molecular dimensions of gastrointestinal tumors: Some thoughts for digestion

American Journal of Medical Genetics

Volumn 122 A, Issue 4, 2003, Pages 303-314

  Cohen Jr , M Michael ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

APC; BMPR1A; Colorectal cancer; FGF FGFR; Gastrointestinal stromal tumors; Mismatch repair genes; MLH1; MSH2; MSH6; Mucins; MYH; Neoplasms; Peutz Jeghers syndrome; PMS1; Polyposis; PTCH; PTEN hamartoma tumor syndrome; RUNX3; STK11; TGF SMADs; WNT; catenin

Indexed keywords

APC PROTEIN; BETA CATENIN; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR RECEPTOR; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PROTEIN; PROTEIN KIT; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6; PROTEIN PMS1; TRANSCRIPTION FACTOR RUNX3; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; WNT PROTEIN;

AUTOSOMAL RECESSIVE DISORDER; CARCINOGENESIS; COLON POLYP; COLORECTAL CANCER; CONFERENCE PAPER; DIGESTION; GASTROINTESTINAL TUMOR; GENE MUTATION; GENE REPRESSION; HUMAN; MISMATCH REPAIR; PEUTZ JEGHERS SYNDROME; PRIORITY JOURNAL; STOMACH CANCER; STOMACH CARCINOMA;

EID: 0141890121     PISSN: 15524825     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajmg.a.20473     Document Type: Conference Paper

References (137)

1. Albuquerque C, Breukel C, van der Luijt R, Fidalgo P, Lage P, Slors FJM, Leitao CN, Fodde R, Smits R. 2002. The 'just-right' signaling model: APC somatic mutations are selected based on a specific level of activation of the β-catenin signaling cascade. Hum Mol Genet 11:1549-1560.
2. Al-Tassan N, Chmiel NH, Maynard J, Fleming N, Livingston AL, Williams GT, Hodges AK, Davies DR, David SS, Sampson JR, Cheadle JP. 2002. Inherited variants of MYH associated with somatic G:C → T:A mutations in colorectal tumors. Nat Genet 30:227-232.
3. Amos CI, Bali D, Thil TJ, Anderson JP, Gourley I, Frazier ML, Lynch PM, Luchtefeld MA, Young A, McGarrity TJ, Seldin MF. 1997. Fine mapping of a genetic locus for Peutz-Jeghers syndrome on chromosome 19p. Cancer Res 57:3653-3656.
4. Arch EM, Goodman BK, Van Wesep RA. 1997. Deletion of PTEN in a patient with Bannayan-Riley-Ruvalcaba syndrome suggests allelism with Cowden disease. Am J Med Genet 71:489-493.
5. Bannayan GA. 1971. Lipomatosis, angiomatosis and macroencephaly: a previously undescribed congenital syndrome. Arch Pathol 92:1-5.
6. Bellacosa A, Genuardi M, Anti M, Viel A, Ponz de Leon M. 1996. Hereditary nonpolyposis colorectal cancer: review of clinical, molecular genetics, and counseling aspects. Am J Med Genet 62:353-364.
7. Blobe GC, Schiemann WP, Lodish HF. 2000. Role of transforming growth factor β in human disease. N Engl J Med 342:1350-1358.
8. Bodmer WF, Bailey CJ, Bodmer J. 1987. Localisation of the gene for familial adenomatous polyposis on chromosome 5. Nature 328:614-619.
9. Bodmer W, Bishop T, Karran P. 1994. Genetic steps in colorectal cancer. Nat Genet 6:217-219.
10. Bolwell JS, James PD. 1979. Peutz-Jeghers syndrome with pseudoinvasion of hamartomatous polyps and multiple epithelial neoplasms. Histopathology 3:39-50.
11. Bowlby LS. 1986. Pancreatic adenocarcinoma in an adolescent male with Peutz-Jeghers syndrome. Hum Pathol 17:97-99.
12. Bronner CE, Baker SM, Morrison PT, Warren G, Smith LG, Lescoe MK, Kane M, Earabino C, Lipford J, Lindblom A, Tannergård P, Bollag RJ, Godwin AR, Ward DC, Nordenskjøld M, Fishel R, Kolodner R, Liskay RM. 1994. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 368:258-261.
13. Bunyan DJ, Shea-Simonds J, Reck AC, Finnis D, Eccles DM. 1995. Genotype-phenotype correlations of new causative APC gene mutations in patients with familial adenomatous polyposis. J Med Genet 32:728-731.
14. Burt DW, Jakowlew SB. 1992. Correction: a new interpretation of a chicken transforming growth factor β4 complementary DNA. Mol Enocrinol 6:989-992.
15. Burt DW, Paton JR. 1992. Evolutionary origins of the transforming growth factor-β gene family. DNA Cell Biol 11:497-510.
16. Carey JC, Viskochil DH. 1999. Neurofibromatosis type 1: a model condition for the study of the molecular basis of variable expressivity in human disorders. Am J Med Genet 89:7-13.
17. Çelebi JT, Chen FF, Zhang H, Ping XL, Tsou HC, Peacocke M. 1999. Identification of PTEN mutations in five families with Bannayan-Zonana syndrome. Exp Dermatol 8:134-140.
18. Çelebi JT, Wanner M, Ping XL, Zhang H, Peacocke M. 2000. Association of splicing defects in PTEN leading to exon skipping or partial intron retention in Cowden syndrome. Hum Genet 107:234-238.
19. Cohen MM Jr. 1990. Bannayan-Riley-Ruvalcaba syndrome. Renaming a condition previously thought to represent three separate entities. Am J Med Genet 35:291.
20. Cohen MM Jr. 1998. Some neoplasms and some hamartomatous syndromes: genetic considerations. Int J Oral Maxiliofac Surg 27:363-369.
21. Cohen MM Jr. 2001. RUNX genes, neoplasia, and cleidocranial dysplasia. Am J Med Genet 104:185-188.
22. Cohen MM Jr. 2002. Bone morphogenetic proteins with some comments on fibrodysplasia ossificans progressiva and NOGGIN. Am J Med Genet 109:87-92.
23. Cohen MM Jr. 2003. TGFβ/Smad signaling system and its pathologic correlates. Am J Med Genet 116A:1-10.
24. Cohen MM Jr. 2003. Neoplasms associated with alterations in fibroblast growth factor receptors. Am J Med Genet 119A:97-100.
25. Cohen MM Jr, Neri G, Weksberg R. 2002. Overgrowth Syndromes. New York: Oxford University Press.
26. Cumberledge S, Reichsman F. 1997. Glycosaminoglycans and WNTs: just a spoonful of sugar helps the signal go dowm. Trends Genet 13:421-423.
27. Dann CE, Hsieh J-C, Rattner A, Sharma D, Nathans J, Leahy DJ. 2001. Insights into Wnt binding and signalling from the structures of two Frizzled cysteine-rich domains. Nature 412:86-90.
28. Davies DR, Armstrong JG, Thakker N, Horner K, Guy SP, Clancy T, Sloan P, Blair V, Dodd C, Warnes TW, Harris R, Evans DGR. 1995. Severe Gardner syndrome in families with mutations restricted to a specific region of the APC gene. Am J Hum Genet 57:1151-1158.
29. DeBaun MR, Niemitz EL, Feinberg AP. 2003. Association of in vitro fertilization with Beckwith-Wiedemann syndrome and epigenetic alterations of LIT1 and H19. Am J Hum Genet 72:156-160.
30. Dong SM, Kim KM, Kim SY, Shin MS, Na EY, Lee SH, Park WS, Yoo NJ, Jang JJ, Yoon CY, Kim JW, Kim SY, Yang YM, Kim SH, Kim CS, Lee JY. 1998. Frequent somatic mutations in Serine/Threonine Kinase II/Peutz-Jeghers syndrome gene in left-sided colon cancer. Cancer Res 58:3767-3790.
31. Dvir M, Beer S, Aladjem M. 1988. Heredofamilial syndrome of mesodermal hamartomas, macrocephaly and pseudopapilledema. Pediatrics 81:287-290.
32. Fargnoli MC, Orlow SJ, Semel-Concepcion J, Bolognia JL. 1996. Clinicopathologic findings in the Bannayan-Riley-Ruvalcaba syndrome. Arch Dermatol 132:1214-1218.
33. Fishel R. 1998. Mismatch repair, molecular switches, and signal transduction. Genes Dev 12:2096-2101.
34. Fishel R, Lescoe MK, Rao MRS, Copeland NG, Jenkins NA, Garber J, Kane M, Kolodner R. 1993. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 75:1027-1038.
35. Foster MA, Kilkoyne RF. 1986. Ruvalcaba-Myhre-Smith syndrome: a new consideration in the differential diagnosis of intestinal polyposis. Gastrointest Radiol 11:349-350.
36. Froggatt NJ, Brassett C, Koch DJ, Evans DGR, Hodgson SV, Ponder BA, Maher ER. 1996. Mutation screening of MSH2 and MLH1 mRNA in hereditary non-polyposis colon cancer syndrome. J Med Genet 33:726-730.
37. Gendler SJ, Spicer AP. 1995. Epithelial mucin genes. Annu Rev Physiol 57:607-634.
38. Giardiello FM, Welsh SB, Hamilton SR, Offerhaus GJA, Gittelsohn AM, Booker SV, Krush AJ, Yardley LH, Luk GD. 1987. Increased risk of cancer in the Peutz-Jeghers syndrome. N Engl J Med 316:1511-1514.
39. Gorlin RJ, Cohen MM Jr, Condon LM, Burke BA. 1992. Bannayan-Riley-Ruvalcaba syndrome. Am J Med Genet 44:307-314.
40. Gorlin RJ, Cohen MM Jr, Hennekam RCM. 2001. Syndromes of the Head and Neck, Fourth Edition. New York: Oxford University Press.
41. Grady WM, Myeroff LL, Swinler SE. 1999. Mutational inactivation of transforming growth factor β receptor type II in microsatellite stable colon cancers. Cancer Res 59:320-324.
42. Groden J, Thliveris A, Samowitz W. 1992. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66:589-600.
43. Hahn SA, Schutte M, Hoque ATMS, Moskaluk CA, da Costa LT, Rozenblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban RH, Kern SE. 1996. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271:350-353.
44. Hahn H, Wojnowski L, Miller G, Zimmer A. 1999. The patched signaling pathway in tumorigenesis and development: lessons from animal models. J Mol Med 77:459-468.
45. Halford SER, Rowan AJ, Lipton L, Sieber OM, Pack K, Thomas HJW, Hodgson SV, Bodmer WF, Tomlinson IPM. 2003. Germline mutations but not somatic changes at the MYH locus contribute to the pathogenesis of unselected colorectal cancers. Am J Pathol 162:1545-1548.
46. Hamilton SR, Liu B, Parsons RE, Papadopoulos N, Jen J, Powell SM, Krush AJ, Berk T, Cohen Z, Tetu B, Burger PC, Wood PA, Taqi F, Booker SV, Petersen GM, Offerhaus GJA, Tersmette AC, Giardiello FM, Vogelstein B, Kinzler KW. 1995. The molecular basis of Turcot's syndrome. N Engl J Med 332:839-847.
47. Hanai J, Chen L-F, Kanno T, Ohtani-Fujita N, Kim W-Y, Guo W-H, Imamura T, Ishidou Y, Fukuchi M, Shi M-J. 1999. Interaction and functional cooperation of PEBP2/CBF with Smads. Synergistic induction of the immunoglobulin germline Calpha promoter. J Biol Chem 274:31577-31582.
48. Heimann R, Verhest A, Verschraegen J, Grosjean W, Draps JP, Hecht F. 1988. Hereditary intestinal neurofibromatosis. I. A distinctive genetic disease. Neurofibromatosis 1:26-32.
49. Heinrich MC, Rubin BP, Longley BJ, Fletcher JA. 2002. Biology and genetic aspects of gastrointestinal stromal tumors: KIT activation and cytogenetic alterations. Hum Pathol 33:484-495.
50. Heinrich MC, Corless CL, Duensing A, McGreevey L, Chen C-J, Joseph N, Singer S, Griffith DJ, Haley A, Town A, Demetri GD, Fletcher CDM, Fletcher JA. 2003. PDGFRA activating mutations in gastrointestinal stromal tumors. Science 299:708-710.
51. Helseth A, Mylius EA. 1986. Gorlin's syndrom. Tidsk Norsk Laegeforen 106:2851.
52. Hemminki A, Tomlinson I, Markie D, Järvinen H, Sistonen P, Björkqvist A-M, Knuutila S, Salovaara R, Bodmer W, Shibata D, Chapelle A, Aaltonen LA. 1997. Localization of a susceptibility locus for Peutz-Jeghers syndrome to 19p using comparative genomic hybridization and targeted linkage analysis. Nat Genet 15:87-90.
53. Hemminki A, Markie D, Tomlinson I, Avizienyte E, Roth S, Loukola A, Bignell G, Warren W, Aminoff M, Höglund P, Järvinen H, Kristo P, Pelin K, Ridanpää M, Salovaara R, Toro T, Bodmer W, Olschwang S, Oslen AS, Stratton MR, de la Chapelle A, Aaltonen LA. 1998. A serine/ threonine kinase gene defective in Peutz-Jeghers syndrome. Nature 391:184-187.
54. Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S, Kawano K, Hanada M, Kurata A, Takeda M, Tunio GM, Matsuzawa Y, Kanakura Y, Shinomura Y, Kitamura Y. 1998. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 279:577-580.
55. Hopyan S, Gokgoz N, Poon R, Gensure RC, Yu C, Cole WC, Bell RS, Jüppner H, Andrulis IL, Wunder JS, Alman BA. 2002. A mutant PTH/PTHrP type I receptor in enchondromatosis. Nat Genet 30:306-310.
56. Howe JR, Roth S, Ringold JC, Summers RW, Jarvinen HJ, Sistonen P, Tomlinson IPM, Houlston RS, Bevan S, Mitros FA, Stone EM, Aaltonen LA. 1998. Mutations in the SMAD4/DPC4 gene in juvenile polyposis. Science 280:1086-1088.
57. Howe JR, Bair JL, Sayed MG, Anderson ME, Mitros FA, Peterson GM, Velculescu VE, Taverso G, Vogelstein B. 2001. Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis. Nat Genet 28:184-187.
58. Huizinga JD, Thuneberg L, Klüppel M, Malysz J, Mikkelsen HB, Bernstein A. 1995. W/kit gene required for interstitial cells of Cajal and for intestinal pacemaker activity. Nature 373:347-349.
59. Ingham PW. 1996. Has the quest for a Wnt receptor finally frizzled out? Trends Genet 12:382-384.
60. Itoh S, Itoh F, Goumane M-J, ten Dijke P. 2000. Signaling of transforming growth factor-β family members through Smad proteins. Eur J Biochem 267:6954-6967.
61. Jang J-H, Shin K-H, Park Y-J, Lee RJ, McKeehan WL, Park J-G. 2000. Novel transcripts of fibroblast growth factor receptor 3 reveal aberrant splicing and activation of cryptic splice sequences in colorectal cancer. Cancer Res 60:4049-4052.
62. Jang J-H, Shin K-H, Park J-G. 2001. Mutations in fibroblast growth factor receptor 2 and fibroblast growth factor receptor 3 genes associated with human gastric and colorectal cancers. Cancer Res 61:3541-3543.
63. Jenne DE, Reiman H, Nezu JI, Friedel W, Loff S, Jeschke R, Muller O, Back W, Zimmer M. 1998. Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat Genet 18:38-44.
64. Jiricny J, Nyström-Lahti M. 2000. Mismatch repair defects in cancer. Curr Opin Genet Dev 10:157-161.
65. Johnson JL, Webster JR Jr, Sippy HI. 1960. Maffucci's syndrome (dyschondroplasia with hemangiomas). Am J Med 28:864-866.
66. Jones S, Emmerson P, Maynard J, Best JM, Jordan S, Williams GT, Sampson JR, Cheadle JP. 2002. Biallelic germline mutations in MYH predispose to multiple colorectal adenomas and somatic G:C to T:A mutations. Hum Molec Genet 11:2961-2967.
67. Kahn LB, Gordon W. 1967. Basal cell naevus syndrome. S Afr Med J 41:832-835.
68. Kindblom LG, Remotti HE, Aldenborg F, Meis-Kindblom JM. 1998. Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am J Pathol 152:1259-1269.
69. Kinzler KW, Vogelstein B. 1996. Lessons from hereditary colorectal cancer. Cell 87:159-170.
70. Kinzler KW, Nilbert MC, Su L. 1991. Identification of FAP locus genes from chromosome 5q21. Science 253:661-664.
71. Kobrin MS, Yamanaka Y, Friess H, Lopez ME, Korc M. 1993. Aberrant expression of type 1 fibroblast growth factor receptor in human pancreatic adenocarcinomas. Cancer Res 53:4741-4744.
72. Kruse R, Rütten A, Lamberti C, Hosseiny-Malaveri HR, Wang Y, Ruelfs C, Jungck M, Mathiak M, Ruzicka T, Hartschuh W, Bisceglia M, Friedl W, Propping P. 1998. Muir-Torre phenotype has a frequency of DNA mismatch-repair-gene mutations similar to that in hereditary nonpolyposis colorectal cancer families defined by the Amsterdam criteria. Am J Hum Genet 63:63-70.
73. 2+ pathway: a new vertebrate Wnt signaling pathway takes shape. Trends Genet 16:279-282.
74. Leach FS, Nicolaides NC, Papadopoulos N, Liu B, Jen J, Parsons R, Peltomäki P, Sistonen P, Aaltonen LA, Nyström-Lahti M, Guan X-Y, Zhang J, Meltzer PS, Yu J-W, Kao F-T, Chen DJ, Cerosaletti KM, Fournier REK, Todd S, Lewis T, Leach RJ, Naylor SL, Weissenbach J, Mecklin J-P, Järvinen H, Petersen GM, Hamilton SR, Green J, Jass J, Watson P, Lynch HT, Trent JM, de la Chapelle A, Kinzler KW, Vogelstein B. 1993. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 75:1215-1225.
75. Li Q-L, Ito K, Sakakura C, Fukamachi H, Inoue K-i, Chi X-Z, Lee K-Y, Nomura S, Lee C-W, Han S-B, Kim H-M, Kim W-J, Yamamoto H, Yamashita N, Yano T, Ikeda T, Itohara S, Inazawa J, Abe T, Hagiwara A, Yamagishi H, Ooe A, Kaneda A, Sugimura T, Ushijima T, Bae S-C, Ito Y. 2002. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 109:113-124.
76. Liu B, Parsons RE, Hamilton SR, Petersen GM, Lynch HT, Watson P, Markowitz S, Willson JKV, Green J, de la Chapelle A, Kinzler KW, Vogelstein B. 1994. hMSH2 mutations in hereditary nonpolyposis colorectal cancer kindreds. Cancer Res 54:4590-4594.
77. Lowichik A, White FV, Timmons CF, Weinberg AG, Gunasekaran TS, Nathan K, Coffin CM. 2000. Bannayan-Riley-Ruvalcaba syndrome: spectrum of intestinal pathology including juvenile polyps. Pediatr Dev Pathol 3:155-161.
78. Lux ML, Rubin BP, Biase TL, Chen C-J, Maclure T, Demetri G, Xiao S, Singer S, Fletcher CDM, Fletcher JA. 2000. KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors. Am J Pathol 156:791-795.
79. Lynch HT, Lynch JF. 1993. The Lynch syndromes. Curr Opin Oncol 5:687-696.
80. Lynch HT, Fusaro RM, Roberts L, Voorhees GJ, Lynch JF. 1985. Muir-Torre syndrome in several members of a family with a variant of the cancer family syndrome. Br J Dermatol 113:295-301.
81. Lynch HT, Lanspa S, Smyrk T, Boman B, Watson P, Lynch J. 1991. Hereditary nonpolyposis colorectai cancer (Lynch syndromes I & II). Genetics, pathology, natural history, and cancer control. Part I. Cancer Genet Cytogenet 53:143-160.
82. Machara Y, Kakeji Y, Kabashima A. 1999. Role of transforming growth factor-β1 in invasion and metastasis in gastric carcinoma. J Clin Oncol 17:607-614.
83. Maesawa C, Tamura G, Iwaya T. 1998. Mutations in the human homologue of the Drosophila Patched gene in esophageal squamous cell carcinoma. Genes Chromosomes Cancer 21:276-279.
84. Malkhosyan S, Rampino N, Yamamoto H, Perucho M. 1996. Frameshift mutator mutations. Nature 382:499-500.
85. Markowitz S, Wang J, Myeroff I, Parsons R, Sun L, Lutterbaugh J, Fan RS. 1995. Inactivation of the type II TGF-βreceptor in colon cancer cells with microsatellite instability. Science 268:1336-1338.
86. Marra G, Jiricny J. 2003. Multiple colorectal adenomas-is their number up? New Engl J Med 348:845-847.
87. Marsh DJ, Dahia PLM, Zheng Z, Liaw D, Parsons R, Gorlin RJ, Eng C. 1997. Germline mutations in PTEN are present in Bannayan-Zonona syndrome. Nat Genet 16:333-334.
88. Marsh DJ, Coulon V, Lunetta KL, Rocca-Serra P, Dahia PLM, Zheng Z, Liaw D, Caron S, Cuboue B, Lin AY, Richardson AL, Bonnetblanc J-M, Bressieux J-M, Cabarrot-Moreau A, Chompret A, Damange L, Ecles RA, Yahanda AM, Fearson ER, Fricker J-P, Gorlin RJ, Hodgson SV, Huson S, Lacombe D, LePrat F, Odent S, Toulouse C, Olopade OI, Sobol H, Tishler S, Woods CG, Robinson BG, Weber HC, Parsons R, Peacocke M, Longy M, Eng C. 1998. Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutations. Hum Mol Genet 7:507-517.
89. Marsh DJ, Kum JB, Lunetta KL, Bennett MJ, Gorlin RJ, Ahmed SF, Bodurtha J, Crowe C, Curtis MA, Dasouki M, Dunn T, Feit H, Geraghty MT, Graham JM Jr, Hodgson SV, Hunter A, Korf BR, Manchester D, Miesfeldt S, Murday VA, Nathanson KL, Parisi M, Pober B, Romano C, Tolmie JL, Trembath R, Winter RM, Zackai EH, Zori RT, Weng L-P, Dahia PLM, Eng C. 1999. PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome. Hum Mol Genet 8:1461-1472.
90. Massagué J, Wotton D. 2000. Transcriptional control by the TGFβ/Smad signaling system. EMBO J 19:1745-1754.
91. McGoldrick JP, Yeh Y-C, Solomon M, Essigmann JM, Lu A-L. 1995. Characterization of a mammalian homolog of the Escherichia coli MutY mismatch repair protein. Molec Cell Biol 15:989-996.
92. 2+ pathways. Oncogene 18:7860-7872.
93. Miyaki M, Konishi M, Tanaka K, Kikuchi-Yanoshita R, Muraoka M, Yasuno M, Igari T, Koike M, Chiba M, Mori T. 1997. Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer. Nat Genet 17:271-272.
94. Miyazono K, ten Duke P, Heldin C-H. 2000. TGF-β signaling by Smad proteins. Adv Immunol 75:115-157.
95. Moon RT, Brown JD, Torres M. 1997. WNTs modulate cell fate and behavior during vertebrate development. Trends Genet 13:157-162.
96. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, Kinzler KW. 1997. Activation of β-Catenin-Tcf signaling in colon cancer by mutations in β-Catenin or APC. Science 275:1787-1790.
97. Myeroff LL, Parsons R, Kim SJ. 1995. A transforming growth factor β receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. Cancer Res 55:5545-5547.
98. Nicolaides NC, Papadopoulos N, Liu B, Wei Y-F, Carter KC, Ruben SM, Rosen CA, Haseltine WA, Fleischmann RD, Fraser CM, Adams MD, Venter JC, Dunlop MG, Hamilton SR, Petersen GM, de la Chapelle A, Vogelstein B, Kinzler KW. 1994. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 371:75-80.
99. Nusse R. 1999. WNT targets: repression and activation. Trends Genet 15:1-3.
100. Palombo F, Gallinari P, Iaccarino I, Lettieri T, Hughes M, D'Arrigo A, Truong O, Hsuan JJ, Jiricny J. 1995. GTBP, a 160-kilodalton protein essential for mismatch-binding activity in human cells. Science 268:1912-1914.
101. Papadopoulos N, Nicolaides NC, Wei Y-F, Ruben SM, Carter KC, Rosen CA, Haseltine WA, Fleischmann RD, Fraser CM, Adams MD, Venter JC, Hamilton SR, Petersen GM, Watson P, Lynch HT, Peltomäki P, Mecklin J-P, de la Chapelle A, Kinzler KW, Vogelstein B. 1994. Mutation of a mutL homolog in hereditary colon cancer. Science 263:1625-1629.
102. Papadopoulos N, Nicolaides N, Liu B, Parsons R, Lengauer C, Palombo F, D'Arrigo A, Markowitz S, Willson JKV, Kinzler KW, Jiricny J, Vogelstein B. 1995. Mutations of GTBP in genetically unstable cells. Science 268:1915-1917.
103. Reis CA, David L, Correa P, Carneiro F, de Bolós C, Garcia E, Mandel U, Clausen H, Sobrinho-Simoes M. 1999. Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression. Cancer Res 59:1003-1007.
104. Riley HD, Smith WR. 1960. Macrocephaly, pseudopapilledema and multiple hemangiomata. Pediatrics 26:293-300.
105. Rizki A, Lundblad V. 2001. Defects in mismatch repair promote telomerase-independent proliferation. Nature 411:713-716.
106. Robinson TL, Sircar K, Hewlett BR, Chorneyko K, Riddell RH, Huizinga JD. 2000. Gastrointestinal stromal tumors may originate from a subset of CD34-positive interstitial cells of Cajal. Am J Pathol 156:1157-1163.
107. Rowan AJ, Lamlum H, Ilyas M, Wheeler J, Straub J, Papadopoulou A, Bicknell D, Bodmer WF, Tomlinson IPM. 2000. APC mutations in sporadic colorectal tumors: a mutational "hotspot" and interdependence of the "two hits". Proc Natl Acad Sci USA 97:3352-3357.
108. Rubin BP, Singer S, Tsao C, Duensing A, Lux ML, Ruiz R, Hibbard MK, Chen C-J, Xiao S, Tuveson DA, Demetri GD, Fletcher CDM, Fletcher JA. 2001. KIT activation is a ubiquitous feature of gastrointestinal stromal tumors. Cancer Res 61:8118-8121.
109. Ruvalcaba RHA, Myhre S, Smith DW. 1980. Sotos syndrome with intestinal polyposis and pigmentary changes of the genitalia. Clin Genet 18:413-416.
110. Sachatello CR, Hahn IS, Carrington CP. 1974. Juvenile gastrointestinal polyposis in a female infant: report of a case and review of the literature of a recently recognized syndrome. Surgery 75:107-114.
111. Sakurai S, Fukasawa T, Chong JM, Tanaka A, Fukayama M. 1999. Embryonic form of smooth muscle myosin heavy chain (SMemb/MHC-B) in gastrointestinal stromal tumor and interstitial cells of Cajal. Am J Pathol 154:23-28.
112. Shah RNH, Ibbitt JC, Alitalo K, Hurst HC. 2002. FGFR4 overexpression in pancreatic cancer is mediated by an intronic enhancer activated by HNF1α Oncogene 21:8251-8261.
113. Sia EA, Jinks-Robertson S, Petes TD. 1997. Genetic control of microsatellite stability. Mutat Res 383:61-70.
114. Sieber OM, Lipton L, Crabtree M, Heinimann K, Fidalgo P, Phillips RKS, Bisgaard M-L, Orntoft TF, Aaltonen LA, Hodgson SV, Thomas HJW, Tomlinson IPM. 2003. Multiple colorectal adenomas, classic adenomatous polyposis, and germline mutations in MYH. New Engl J Med 348:791-799.
115. Silva F, Carvalho F, Peixota A, Seixas M, Almeida R, Carneiro F, Mesquita P, Figueiredo C, Nogueira C, Swallow DM, Amorim A, David L. 2001. MUC1 gene polymorphism in the gastric carcinogenesis pathway. Eur J Hum Genet 9:548-552.
116. Sircar K, Hewlett BR, Huizinga JD, Chorneyko K, Berezin I, Riddell RH. 1999. Interstitial cells of Cajal as precursors of gastrointestinal stromal tumors. Am J Surg Pathol 23:377-389.
117. Slupska MM, Baikalov C, Luther WM, Chiang J-H, Wei Y-F, Miller JH. 1996. Cloning and sequencing a human homolog (hMYH) of the Escherichia coli mutY gene whose function is required for the repair of oxidative DNA damage. J Bacteriol 178:3885-3892.
118. Spirio LN, Samowitz W, Robertson J, Robertson M, Burt RW, Leppert M, White R. 1998. Alleles of APC modulate the frequency and classes of mutations that lead to colon polyps. Nat Genet 20:385-388.
119. Sun T-C, Swee RG, Shives TC, Unni KK. 1985. Chondrosarcoma in Maffucci's syndrome. J Bone Joint Surg 67A:1214-1219.
120. Taipale J, Beachy PA. 2001. The Hedgehog and Wnt signalling pathways in cancer. Nature 411:349-354.
121. Taipale J, Saharinen J, Keski-Oja J. 1998. Extracellular matrix-associated transforming growth factor-β: role in cancer cell growth and invasion. Adv Cancer Res 75:87-134.
122. Taniguchi M, Nishida T, Hirota S, Isozaki K, Ito T, Nomura T, Matsuda H, Kitamura Y. 1999. Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors. Cancer Res 59:4297-4300.
123. Taylor WB, Anderson DE, Howell JB, Thurston CS. 1968. The nevoid basal cell carcinoma syndrome. Arch Dermatol 98:612-614.
124. Thiagalingam S, Lengauer C, Leach PS. 1996. Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nat Genet 13:343-346.
125. Thomas DC, Umar A, Kunkel TA. 1996. Microsatellite instability and mismatch repair defects in cancer. Mutat Res 350:201-205.
126. van Heyningen V. 1994. One gene-four syndromes. Nature 367:319-320.
127. Verhest A, Verschraegen J, Grosjean W, Draps JP, Vamos E, Heimann R, Hecht F. 1988. Hereditary intestinal neurofibromatosis. II. Translocation between chromosomes 12 and 14. Neurofibromatosis 1:33-36.
128. Villanueva A, Garcia C, Paules AB. 1998. Disruption of the antiproliferative TGF-β signaling pathways in human pancreatic cancer cells. Oncogene 17:1969-1978.
129. Wagner A, Barrows A, Wijnen JT, van der Klift H, Franken PF, Verkuijlen P, Nakagawa H, Geugien M, Jaghmohan-Changur S, Breukel C, Meijers-Heijboer H, Morreau H, van Puijenbroek M, Burn J, Coronel S, Kinarski Y, Okimoto R, Watson P, Lynch JF, de la Chapelle A, Lynch HT, Fodde R. 2003. Molecular analysis of hereditary nonpolyposis colorectal cancer in the United States: high mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 gene. Am J Hum Genet 72:1088-1100.
130. Walon C, Kartheuser A, Michils G, Smaers M, Lannoy N, Ngounou P, Mertens G, Verellen-Dumoulin C. 1997. Novel germline mutations in the APC gene and their phenotypic spectrum in familial adenomatous polyposis kindreds. Hum Genet 100:601-605.
131. Wang T-L, Rago C, Silliman N, Ptak J, Markowitz S, Willson JKV, Parmigiani G, Kinzler KW, Vogelstein B, Velculescu VE. 2002. Prevalence of somatic alterations in the colorectal cancer cell genome. Proc Nat Acad Sci USA 99:3076-3080.
132. Wehner M, Buschhausen L, Lamberti C, Kruse R, Caspari R, Propping P, Friedl W. 1997. Hereditary nonpolyposis colorectal cancer (HNPCC): Eight novel germline mutations in hMSH2 or hMLH1 genes. Hum Mutat 10:241-244.
133. Wijnen J, Vasen H, Khan PM, Menko FH, van der Klift H, van Leeuwen C, van den Broek M, van Leeuwen-Cornelisse I, Nagengast F, Meijers-Heijboer A, Lindhout D, Griffioen G, Cats A, Kleibeuker J, Varesco L, Bertario L, Bisgaard ML, Mohr J, Fodde R. 1995. Seven new mutations in hMSH2, an HNPCC gene, identified by denaturing gradient-gel electrophoresis. Am J Hum Genet 56:1060-1066.
134. Yang X, Letterio JJ, Lechleider RJ, Chen L, Hayman R, Gu H, Roberts AB, Deng C. 1999. Targeted disruption of Smad3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-β EMBO J 18:1280-1291.
135. Zhou X-P, Woodford-Richens K, Lehtonen R, Kurose K, Aldred M, Hampel H, Launonen V, Virta S, Pilarski R, Salovaara R, Bodmer WF, Conrad BA, Dunlop M, Hodgson SV, Iwama T, Jävinen H, Kellokumpu I, Kim JC, Leggett B, Markie D, Mecklin J-P, Neale K, Phillips R, Piris J, Rozen P, Houlston RS, Aaltonen LA, Tomlinson IPM, Eng C. 2001. Germline mutations in BMPR1A/ALK3 cause a subset of cases of juvenile polyposis syndrome and of Cowden and Bannayan-Riley-Ruvalcaba syndromes. Am J Hum Genet 69:704-711.
136. Zhu Y, Richardson JA, Parada LF, Graff JM. 1998. Smad3 mutant mice develop metastatic colorectal cancer. Cell 94:703-714.
137. Zori RT, Marsh DJ, Graham GE, Marliss EB, Eng C. 1998. Germline PTEN mutation in a family with Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome. Am J Med Genet 80:399-402.